Word

SANGENZA

Status

Dead

Status Code

606

Status Date

Monday, October 9, 2023

Serial Number

90382655

Mark Type

4000

Filing Date

Tuesday, December 15, 2020

Published for Opposition

Tuesday, July 13, 2021

Abandoned Date

Monday, October 9, 2023

Trademark Owner History

Sarepta Therapeutics, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases

Trademark Events

Oct 10, 2023

Abandonment Notice E-Mailed - No Use Statement Filed

Oct 9, 2023

Abandonment - No Use Statement Filed

Feb 21, 2023

Notice Of Approval Of Extension Request E-Mailed

Feb 17, 2023

Sou Extension 3 Granted

Feb 17, 2023

Sou Extension 3 Filed

Feb 17, 2023

Sou Teas Extension Received

Sep 8, 2022

Notice Of Approval Of Extension Request E-Mailed

Sep 6, 2022

Sou Extension 2 Granted

Sep 6, 2022

Sou Extension 2 Filed

Sep 6, 2022

Sou Teas Extension Received

Feb 19, 2022

Notice Of Approval Of Extension Request E-Mailed

Feb 17, 2022

Sou Extension 1 Granted

Feb 17, 2022

Sou Extension 1 Filed

Feb 17, 2022

Sou Teas Extension Received

Sep 7, 2021

Noa E-Mailed - Sou Required From Applicant

Jul 13, 2021

Official Gazette Publication Confirmation E-Mailed

Jul 13, 2021

Published For Opposition

Jun 23, 2021

Notification Of Notice Of Publication E-Mailed

Jun 4, 2021

Approved For Pub - Principal Register

Jun 3, 2021

Teas/Email Correspondence Entered

Jun 3, 2021

Correspondence Received In Law Office

Jun 3, 2021

Teas Response To Office Action Received

May 31, 2021

Notification Of Non-Final Action E-Mailed

May 31, 2021

Non-Final Action E-Mailed

May 31, 2021

Non-Final Action Written

May 29, 2021

Assigned To Examiner

Feb 23, 2021

New Application Office Supplied Data Entered

Dec 18, 2020

New Application Entered